Plain-English translation of NCT05937477 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →Researchers want to understand how to predict chemotherapy side effects before they happen. You'll wear a device that tracks your body's signals and use an app to report how you're feeling. By combining this information with a one-time blood test, the study aims to build an artificial intelligence system that can warn patients and doctors about side effects early, so they can be managed better.
Chemotherapy can cause many difficult side effects, and patients often don't know what to expect. If doctors could predict which side effects you're likely to experience, they could prepare you and help manage them more effectively, improving your quality of life during treatment.
You will wear a device that continuously tracks your health signals and use a smartphone app to report your symptoms and side effects throughout your chemotherapy treatment. At some point during the study, you'll also give one blood sample for genetic testing. The research team will compare all this information to understand patterns between what the device measures and the side effects you actually experience.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea
Enrollment target
~500 participants
Started
June 2023
Primary completion
December 2025
Age range
20 Years and older
Last updated on clinicaltrials.gov in July 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sehhoon Park, MD
Sehhoon Park